Willbase Co., Ltd.
Published “Examples of 48 OTC products”. In addition to providing OTC sales support tools, we will strongly support insurance pharmacies in meeting the requirements for regional support system additions and OTC sales.
……
Willbase Co., Ltd. (Headquarters: Chuo-ku, Tokyo, Representative: Hiroki Tanaka) has announced the release of the book supervised by Shingo Suzuki, author of “Pharmacy OTC Sales Manual: From Clinical Knowledge to Product Selection (Nikkei BP).” In addition to publishing “Examples of 48 OTC drug efficacy groups”, we will also provide the OTC sales support tool “D Counselor neo” to help insurance pharmacies meet the requirements for local support system additions and appropriately sell OTC drugs to consumers. We would like to announce that we will provide support.
■Background of this press release In the 2024 dispensing fee revision, handling of items in the 48 OTC drug efficacy groups was added as a calculation requirement for regional support system additions. There have also been negative comments from people working in insurance pharmacies, such as, “Is it really necessary to have it in pharmacies when there are so many products available at drugstores?” and “I don’t expect it to sell well.” There are some items that even pharmacists have never seen before, so some people are wondering, “What kind of OTC drugs should I stockpile?” and “Will it really sell out even if I stock it (will it result in loss)?” There are also voices of concern.
■Example of products from OTC48 medicinal group
Under these circumstances, under the supervision of Mr. Shingo Suzuki, who has extensive experience in OTC sales as a pharmacist and is well-known for his books on OTC, in order to help insurance pharmacies who are confused about the selection of products from the OTC 48 efficacy group, we have We have created “Examples of products in the 48 OTC efficacy groups” that take into account a wide range of factors, such as product characteristics, the age of the visitor, and medical history, as well as “examples of products in the 48 OTC efficacy groups” that meet the requirements for local support system additions. -Examples of products from the OTC48 medicinal efficacy group (excerpt)-
[Image 1: https://prtimes.jp/i/72976/12/resize/d72976-12-dc536612bcc3c7cd0410-0.png&s3=72976-12-5fbf804c12757370e434e0fc763fc465-2723×2175.png ]
* Shingo Suzuki’s biography: Active pharmacist working at a pharmacy. Director of Yokohama City Nishi Ward Pharmacists Association. After working at a major drugstore, he started selling OTC drugs at an insurance pharmacy that mainly dispensed prescriptions. In addition to disseminating useful information on OTC drugs to pharmacists and registered drug distributors on SNS, he is also active in a variety of fields, including media appearances, lectures all over the country, and a series on Nikkei DI Premium. His books, “Pharmacy OTC Sales Manual: Understanding everything from clinical knowledge to product selection (Nikkei BP)” and “Examples of products from 48 OTC drug efficacy groups,” along with selection points, can be viewed on the website below. https://curebell.jp/articles/578/
*The above site is linked with CureBell (Cure Bell:
https://curebell.jp/), an OTC selection support web application provided by our company to consumers, and each OTC drug presented on the above site You can refer to detailed information, attached documents, etc. CureBell covers more than 1,000 types of OTC drugs, and can be used to help select products that suit each pharmacy from various perspectives such as category, range of users, reference price, etc. -CureBell screen example-
[Image 2: https://prtimes.jp/i/72976/12/resize/d72976-12-0c1ede5954a9d254cb7c-1.png&s3=72976-12-199ff5e74f901e63c595cafe711be39d-1539×1175.png ]
■Providing OTC sales support tools
In order to support insurance pharmacies in selling out the OTC drugs they have selected and stockpiled, we have developed the OTC sales support tool (tablet device app) “D Counselor neo” (https://www .willbase.co.jp/service/dcounselor.htm) to insurance pharmacies. By using D Counselor neo, it is possible to provide detailed information on OTC drugs to visitors and facilitate detailed explanations by pharmacists, making it possible to appropriately sell selected and stocked products without wasting them. Our consultants will provide advice to insurance pharmacies that are unsure of how to select products from the 48 OTC efficacy groups, explain OTC products, and serve customers.
[Image 3: https://prtimes.jp/i/72976/12/resize/d72976-12-94c628bb1133610ea44c-2.png&s3=72976-12-245917ba818695ee637e5779a5932f9b-1695×1093.png ]
[Image 4: https://prtimes.jp/i/72976/12/resize/d72976-12-cc2876d358da9a710550-5.png&s3=72976-12-c7c4375e41f0a79bb1cc2300a39a4c83-2660×1840.png ]
[Image 5: https://prtimes.jp/i/72976/12/resize/d72976-12-ca8ef29848dfdac24149-4.png&s3=72976-12-54ed2ac2e28bd9b513180578d62a9cab-1725×1110.png ]
■Contents of D Counselor neo
Purpose of use
Supporting visitors to select OTC products using tablet devices Usage form
(1)Pharmacists, etc. present to visitors during explanations (2) Install it in front of the OTC shelf or counter and allow visitors to operate it.
Offer price (excluding tax)
[Initial cost] 500,000 yen ~ (varies depending on the scale of installation) [Monthly fee example]
・20 licenses: 210,000 yen
・100 licenses: 730,000 yen
remarks
D Counselor neo has been selected as an IT tool for the FY2020 IT introduction subsidy, and small and medium-sized enterprises and micro businesses will receive half of the annual usage fee (up to 1.5 million yen) including initial costs. Masu. Please contact us for details.
*Please see below for detailed information.
https://www.willbase.co.jp/service/dcounselor.htm
*If you subscribe to D Counselor neo, we will provide you with free advice regarding the selection and sales of OTC48 drug groups (the scope and period of provision may vary). [About Willbase Co., Ltd.] We help retail and healthcare-related companies maximize the
effectiveness and efficiency of their marketing and promotional activities. We also support consumers in selecting health care products that are safe, secure, and suitable for them, and promote and educate people about self-care and self-medication. Established: December 2016 Location: H1O Nihonbashi Kobune-cho 5F, 8-6 Nihonbashi Kobune-cho, Chuo-ku, Tokyo Capital: 75.4 million yen (including capital reserve) Business details: OTC sales support tool D Counselor neo, OTC for consumers Company that develops and provides selection support web application CureBell, store management support system RetailForce, etc. URL: https://www.willbase.co.jpD Counselor neo: https://www.willbase.co.jp/service /dcounselor.htmlCureBell: https://curebell.jp/
More details about this release:
https://prtimes.jp/main/html/rd/p/000000012.000072976.html